Etiology and mortality markers in atrial fibrillation with rapid ventricular response
Öz
Purpose: The aim of this study was to obtain data on the causes of rapid rate in the patients with atrial fibrillation (AF), the parameters that may be effective in the decision of antiarrhythmic treatment and short-term mortality during the management of the patients with AF with rapid ventricular response.
Materials and Methods: One hundred three patients over 18-year-old were included. Complete blood counts, biochemical and coagulation parameters, venous blood gases of the patients were evaluated. In order to investigate the volume condition, we measure the inferior vena cava (IVC) diameter by bed-side ultrasonography (USG). The mortalities within 15 and 30 days and analyzed the mortality-related parameters of the patients were calculated.
Results: Heart failure or hypervolemia are the most common clinical presentation with 15.5% (n=16) of the AF with rapid ventricular response. 14.6% (n=15) of the patients were treated by treating the underlying condition without giving any antiarrhythmics. A statistically significant correlation was found between lactate level and 15-30 day mortality rates. A statistically significant correlation was found between base excess (BE) and 15-30 day mortality rates.
Conclusion: The measurement of IVC diameter in the patients may lead the physicians to determine the volume condition of the patients, the lactate levels and BE values to predict the short-term mortality and help to decide whether hospitalize or discharge the patients.
Anahtar Kelimeler
Atrial Fibrillation, Inferior Vena Cava, Lactate, Base Excess
Kaynakça
- Referans1. Atriyal Fibrilasyon Tedavi Kılavuzu. Turk Kardiyol Dern Ars. 2010;38(80):1-65.
- Referans2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2014;130(23):e199-e267.
- Referans3. Çelebi Yamanoğlu NG, Yamanoğlu A, Parlak İ, Pınar P, Tosun A, Erkuran B, et al. The role of inferior vena cava diameter in volume status monitoring; the best sonographic measurement method? Am J Emerg Med. 2015;33(3):433-8.
- Referans4. Boldt J, Lenz M, Kumle B, Papsdorf M. Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med. 1998;24(2):147-51.
- Referans5. Miyasaka Y BM, Cha S, Bailey K, Tsang T, . Overall and sex-specific trends and prognosis of ischemic stroke following incident atrial fibrillation: Data from 2 decades (1980-2000). Circulation; Lippincott Williams & Wilkins: Lippincott Williams & Wilkins.
- Referans6. Long B, Robertson J, Koyfman A, Maliel K, Warix JR. Emergency medicine considerations in atrial fibrillation. Am J Emerg Med. 2018;36(6):1070-8.
- Referans7. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996;27(10):1760-4.
- Referans8. Lyon M, Blaivas M, Brannam L. Sonographic measurement of the inferior vena cava as a marker of blood loss. Am J Emerg Med. 2005;23(1):45-50.
- Referans9. Şahin A, Ertekin C, Güloğlu R, Yamaner S, Bilsel Y. THE EFFECTIVENESS OF SHOCK PARAMETERS FOR SHOCK AND MORTALITY DETERMINATION. Ulus Travma Acil Cerrahi Derg. 1997;3(3):233-42.
- Referans10. Karon BS, Scott R, Burritt MF, Santrach PJ. Comparison of lactate values between point-of-care and central laboratory analyzers. American journal of clinical pathology. 2007;128(1):168-71.
